🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Finch Therapeutics Group, Inc.
Market Cap: Lowest
Employees: Lowest
CP101
Finch Therapeutics Group, Inc. is a clinical-stage microbiome therapeutics company developing a novel class of orally administered biological drugs, with a lead candidate CP101 in Phase 3 trials for recurrent Clostridioides difficile infection, and a pipeline for other conditions.
Symbol: FNCH
Recent Price: $10.87
Industry: Biotechnology
CEO: Mr. Matthew P. Blischak J.D.
Sector: Healthcare
Employees: 1
Address: 200 Inner Belt Road, Somerville, MA 02143
Phone: 617 229 6499
Last updated: 2024-12-31